Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission

BMC Infectious Diseases - Tập 8 Số 1 - 2008
Abrar Hussain1, Sheikh Riazuddin1
1Division of Molecular Virology & Molecular Diagnostics, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Leiveven J: Pegasys/RBV Improves Fibrosis in Responders, relapsers & Nonresponders with Advanced Fibrosis. 55th Annual Meeting of the American Association for the Study of Liver Disease:. 2004, October 29 – November 2: Boston, MA, USA

Zein NN, Persing DH: Hepatitis C Genotypes: current trends and future implications. Mayo Clin Proc. 1996, 71: 458-462.

Liew M, Erali M, Page S, Hillyard D, Wittwer C: Hepatitis C Genotyping by Denaturing High-Performance Liquid Chromatography. J Clin Microbiol. 2004, 42 (1): 158-163. 10.1128/JCM.42.1.158-163.2004.

Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH: Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med. 1996, 125: 634-639.

Trepo C: Seminar on hepatitis C. European Commission Public Health Unit. 1994

Dusheiko G, Schmilovitz H, Brown D, McOmish F, Yap PL, Simmonds P: Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1996, 19: 13-18.

McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998, 339: 1485-1492. 10.1056/NEJM199811193392101.

Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V: Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet. 1998, International Hepatitis Interventional Therapy Group (IHIT), 352: 1426-1432. 10.1016/S0140-6736(98)07124-4.

McOmish F, Yap PIL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Heéjjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M, Simmonds P: Geographic distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994, 32: 884-92.

Dusheiko G, Main J, Thomas H: Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol. 1994, 25 (5): 591-8. 10.1016/S0168-8278(96)80225-X.

Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, the Collaborative Study Group: Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 1995, 122: 161-168.

Takada NS, Takase S, Takada A, Date T: Differences in the hepatitis C virus genotypes in different countries. J Hepatol. 1993, 17: 277-283. 10.1016/S0168-8278(05)80205-3.

Abdulkarim AS, Zein NN, Germer JJ, Kolbert CP, Kabbani L, Krajnik KL, Hola A, Agha MN, Tourogman M, Persing DH: Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg. 1998, 59: 571-576.

Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliot RM: Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominantgenotype in the Middle East. J Gen Virol. 1997, 78: 1341-1347.

Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993, 74: 2391-9.

Cha TA, Kolberg J, Irvine B, Stempien M, Beall E, Yano M, Choo QL, Houghton M, Kuo G, Han JH, Urdea MS: Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol. 1992, 29: 2528-2534.

Tokita H, Shrestha SM, Okamoto H, Sakamoto M, Horikita M, Iizuka H, Shrestha S, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol. 1994, 75: 931-936.

Tokita H, Okamoto H, Iizuka H, Kishimoto H, Tsuda F, Lesmana LA, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol. 1996, 77: 293-301.

deLamballerie X, Charrel RN, Attoui H, De Micco P: Classification of hepatitis C virus variants in six major types based on analysis of the envelope 1 and nonstructural 5B genome regions and complete polyprotein sequences. J Gen Virol. 1997, 78: 45-51.

Tokita H, Okamoto H, Iizuka H, Kishimoto J, Tsuda F, Miyakawa Y, Mayumi M: The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7–9 and comparison with those in the other eight genetic groups. J Gen Virol. 1998, 79: 1847-1857.

Idrees M: Detection of Six Serotypes of HCV in anti-HCV Positive Patients and rate of ALT/AST abnormalities. Pak J Microbiol. 2001, 1 (2): 61-65.

Shah HA, Jafri WS, Malik I, Prescott L, Simmonds P: Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol. 1997, 12: 758-761. 10.1111/j.1440-1746.1997.tb00366.x.

Idrees M: Common genotypes of hepatitis C virus present in Pakistan. Pak J Med Res. 2001, 40 (2): 46-49.

Idrees M: Development of an improved HCV Genotyping Assay for the Detection of Common Genotypes and subtypes in Pakistan. J Virol Meth. 2008, 150 (1): 50-56. 10.1016/j.jviromet.2008.03.001.

Poynard T, Bedossa P, Chevallier M, Matturin P, Lemonnier C, Trepo C: A comparison of three Interferon alpha 2b regimens for long terms treatment of chronic non A, non B hepatitis. N Engl J Med. 1995, 332: 1457-62. 10.1056/NEJM199506013322201.

Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxì A, Ling MH, Alvrecht J: Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med. 1998, 339: 1493-1499. 10.1056/NEJM199811193392102.

McHutchison JG, Poynard T, Davis GL, Esteban-Mur R, Harvey J, Ling M, Cort S, Fraud JJ, Albrecht J, Dienstag J: Evaluation of hepatic HCV RNA before and after treatment with interferon alfa 2b or combined with ribavirin in chronic hepatitis. Hepatology. 1999, 30 (Suppl 2): 363A-

Nausbaum JB, Pol S, Nalpas B, Landras P, Berthelot P, Brechot C: Hepatitis C virus type 1b(II) infection in France and Italy. Ann Intern Med. 1995, 12: 161-8.

McOmish F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL, Follett EAC, Simmonds P: Detection of three types of hepatitis C virus in blood donors: investigation of type specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993, 33: 7-13. 10.1046/j.1537-2995.1993.33193142314.x.

Jarvis LM, Ludlam CA, Ellender JA, Nemes L, Field SP, Song E, Chuansumrit A, Preston FE, Simmonds P: Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. Blood. 1996, 87: 3007-11.

Pár A, Gervain J, Gógl A: Hepatitis C virus infection: pathogenesis, diagnosis and treatment. Scand J Gastroenterol Suppl. 1998, 228: 107-14. 10.1080/003655298750026633.

Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, Naik TN, Bhattacharya SK, Mazumder DN: Hepatitis c virus infection in the general population: a community-based study in west bengal, india. Hepatology. 2003, 37 (4): 802-9. 10.1053/jhep.2003.50157.

Singh B, Verma M, Verma K: Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis. 2004, 57 (2): 49-51.

Shinji T, Kyaw Y, Gokan K, Tanaka Y, Ochi K: Analysis of HCV genotypes from blood donors shows three new HCV types 6 subgroups exist in Myanmar. Acta Med Okayama. 2004, 58 (3): 135-42.

Tokita H, Okamoto H, Luengrojanakul P, Vareesangthip K, Chainuvati T, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol. 1995, 76: 2329-2335.

Flor PH, Loureiro , Carmen LLic: Replacement of hepatitis C virus genotype 1b by genotype 2 over a 10 year period in Venezuela. J Clin Gastroenterl. 2007, 41 (5): 518-520. 10.1097/01.mcg.0000248010.55149.ce.

el-Zayadi A, Simmonds P, Dabbous H: Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat. 1996, 3: 261-64. 10.1111/j.1365-2893.1996.tb00052.x.

Xu LZ, Larzul D, Delaporte E: Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol. 1994, 75: 2393-98.

Lyra Andre, Ramrakhiani Sunil, Bacon Bruce, Di Bisceglie Adrian: Infection with Hepatitis C virus Genotype 4 in the United States. J Clin Gastroenterol. 2004, 38 (1): 68-71. 10.1097/00004836-200401000-00014.

Kabir A, Alavian SM, Keyvani H: Distribution of hepatitis C virus in patients infected by different sources and its correlation with clinical and virological parameters: A preliminary study. Comparative Hepatology. 2006, 5: 4-10.1186/1476-5926-5-4. doi:10.1186/1476-5926-5-4

Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Hda N, Benslimane A: HCV genotypes in Morocco. J Med Virol. 1997, 52 (4): 396-8. 10.1002/(SICI)1096-9071(199708)52:4<396::AID-JMV9>3.0.CO;2-X.

Pawlotsky JM, Dussaix E, Simmonds P, Prescott L, Pellet C, Lau-rent-Puig P, Labonne C, Remire J, Darthuy F, Duval J, Buffet C, Etienne JP, Dhumeaux D: Hepatitis C virus (HCV) genotype determination: genotyping versus serotyping. Hepatology. 1995, 22: 359A-10.1016/0270-9139(95)95098-2.

Pawlotsky JM, Bastie A, Pellet C: Significance of indeterminate third-generation hepatitis C virus recombinant Immunoblot assay. J Clin Microbiol. 1996, 34: 80-83.

Khan AJ: Unsafe injections and the transmission of hepatitis B and C in a Periurban community in Pakistan. Bull World Health Organ. 2000, 78: 956-963.

Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SFA, Jafar T: Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis. 2006, 6: 101-10.1186/1471-2334-6-101.

Ministry of Health, Annual report, Director General Health, 2001–2002. Government of Pakistan. 2002